Viewing Study NCT04156269

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-02-12 @ 8:19 AM
Study NCT ID: NCT04156269
Status: UNKNOWN
Last Update Posted: 2019-11-12
First Post: 2019-11-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: BCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple Myeloma
Sponsor: iCell Gene Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BCMA View
None CS1 View
None BCMA-CS1 cCAR T cells View
None CD269 View
None SLAMF7 View